1	4	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_


1	Naturally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	as	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	VAD	_	_	NNP	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	controller	_	_	NN	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	implanted	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	humans	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	because	_	_	IN	_	_	_	_	_
15	their	_	_	PRP$	_	_	_	_	_
16	lifespan	_	_	NN	_	_	_	_	_
17	depends	_	_	VBZ	_	_	_	_	_
18	largely	_	_	RB	_	_	_	_	_
19	on	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	suitability	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	pump	_	_	NN	_	_	_	_	_
25	control	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	we	_	_	PRP	_	_	_	_	_
28	must	_	_	MD	_	_	_	_	_
29	have	_	_	VB	_	_	_	_	_
30	great	_	_	JJ	_	_	_	_	_
31	certainty	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	robustness	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	control	_	_	NN	_	_	_	_	_
38	algorithms	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Continuous	_	_	JJ	_	_	_	_	_
2	flow	_	_	NN	_	_	_	_	_
3	for	_	_	IN	_	_	_	_	_
4	VADs	_	_	NNS	_	_	_	_	_
5	may	_	_	MD	_	_	_	_	_
6	allow	_	_	VB	_	_	_	_	_
7	simulated	_	_	VBN	_	_	_	_	_
8	pulses	_	_	NNS	_	_	_	_	_
9	;	_	_	:	_	_	_	_	_
10	however	_	_	RB	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	until	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	date	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	circulatory	_	_	JJ	_	_	_	_	_
17	assistance	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	despite	_	_	IN	_	_	_	_	_
20	tolerance	_	_	NN	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	left	_	_	VBN	_	_	_	_	_
23	ventricular	_	_	JJ	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	Pao	_	_	NNP	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	continuous	_	_	JJ	_	_	_	_	_
29	flow	_	_	NN	_	_	_	_	_
30	rate	_	_	NN	_	_	_	_	_
31	is	_	_	VBZ	_	_	_	_	_
32	traditionally	_	_	RB	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	a	_	_	DT	_	_	_	_	_
35	medium	_	_	JJ	_	_	_	_	_
36	constant	_	_	JJ	_	_	_	_	_
37	rotation	_	_	NN	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	which	_	_	WDT	_	_	_	_	_
40	always	_	_	RB	_	_	_	_	_
41	decreases	_	_	VBZ	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	pressure	_	_	NN	_	_	_	_	_
44	pulse	_	_	NN	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	types	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	devices	_	_	NNS	_	_	_	_	_
5	generally	_	_	RB	_	_	_	_	_
6	require	_	_	VBP	_	_	_	_	_
7	precise	_	_	JJ	_	_	_	_	_
8	control	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	use	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	sensors	_	_	NNS	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	measure	_	_	VB	_	_	_	_	_
16	flow	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	pressure	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	devices	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	not	_	_	RB	_	_	_	_	_
5	reliable	_	_	JJ	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	owing	_	_	VBG	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	clinical	_	_	JJ	_	_	_	_	_
10	issues	_	_	NNS	_	_	_	_	_
11	such	_	_	JJ	_	_	_	_	_
12	as	_	_	IN	_	_	_	_	_
13	routine	_	_	JJ	_	_	_	_	_
14	calibration	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	blood	_	_	NN	_	_	_	_	_
17	clotting	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	concerns	_	_	NNS	_	_	_	_	_
3	regarding	_	_	VBG	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	reliability	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	implantable	_	_	JJ	_	_	_	_	_
8	sensors	_	_	NNS	_	_	_	_	_
9	have	_	_	VBP	_	_	_	_	_
10	led	_	_	VBN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	search	_	_	NN	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	non-invasive	_	_	JJ	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	sensorless	_	_	JJ	_	_	_	_	_
18	approaches	_	_	NNS	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	identifying	_	_	VBG	_	_	_	_	_
21	analog	_	_	JJ	_	_	_	_	_
22	cardiac	_	_	JJ	_	_	_	_	_
23	preload	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	now	_	_	RB	_	_	_	_	_
3	believe	_	_	VBP	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	non-invasive	_	_	JJ	_	_	_	_	_
6	technology	_	_	NN	_	_	_	_	_
7	has	_	_	VBZ	_	_	_	_	_
8	advanced	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	level	_	_	NN	_	_	_	_	_
12	where	_	_	WRB	_	_	_	_	_
13	it	_	_	PRP	_	_	_	_	_
14	can	_	_	MD	_	_	_	_	_
15	be	_	_	VB	_	_	_	_	_
16	considered	_	_	VBN	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	long-term	_	_	JJ	_	_	_	_	_
19	implantation	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	combined	_	_	VBN	_	_	_	_	_
22	with	_	_	IN	_	_	_	_	_
23	sensorless	_	_	JJ	_	_	_	_	_
24	signals	_	_	NNS	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	form	_	_	VB	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	robust	_	_	JJ	_	_	_	_	_
30	control	_	_	NN	_	_	_	_	_
31	system	_	_	NN	_	_	_	_	_
32	that	_	_	WDT	_	_	_	_	_
33	provides	_	_	VBZ	_	_	_	_	_
34	physiological	_	_	JJ	_	_	_	_	_
35	behavior	_	_	NN	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	RBPs	_	_	NNPS	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	pulsatile	_	_	JJ	_	_	_	_	_
3	flow	_	_	NN	_	_	_	_	_
4	pump	_	_	NN	_	_	_	_	_
5	is	_	_	VBZ	_	_	_	_	_
6	used	_	_	VBN	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	non-invasive	_	_	JJ	_	_	_	_	_
10	substitute	_	_	NN	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	LV	_	_	NN	_	_	_	_	_
14	filling	_	_	VBG	_	_	_	_	_
15	pressure	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	it	_	_	PRP	_	_	_	_	_
19	has	_	_	VBZ	_	_	_	_	_
20	been	_	_	VBN	_	_	_	_	_
21	proven	_	_	VBN	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	be	_	_	VB	_	_	_	_	_
24	closely	_	_	RB	_	_	_	_	_
25	interrelated	_	_	VBN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	pump	_	_	NN	_	_	_	_	_
3	flow	_	_	NN	_	_	_	_	_
4	pulsation	_	_	NN	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	mean	_	_	JJ	_	_	_	_	_
7	flow	_	_	NN	_	_	_	_	_
8	pump	_	_	NN	_	_	_	_	_
9	used	_	_	VBN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	current	_	_	JJ	_	_	_	_	_
13	controller	_	_	NN	_	_	_	_	_
14	can	_	_	MD	_	_	_	_	_
15	be	_	_	VB	_	_	_	_	_
16	estimated	_	_	VBN	_	_	_	_	_
17	using	_	_	VBG	_	_	_	_	_
18	an	_	_	DT	_	_	_	_	_
19	algorithm	_	_	NN	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	flow	_	_	NN	_	_	_	_	_
22	estimation	_	_	NN	_	_	_	_	_
23	previously	_	_	RB	_	_	_	_	_
24	established	_	_	VBN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	our	_	_	PRP$	_	_	_	_	_
27	laboratory	_	_	NN	_	_	_	_	_
28	using	_	_	VBG	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	pump	_	_	NN	_	_	_	_	_
31	speed	_	_	NN	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	current	_	_	NN	_	_	_	_	_
34	that	_	_	WDT	_	_	_	_	_
35	are	_	_	VBP	_	_	_	_	_
36	not	_	_	RB	_	_	_	_	_
37	measured	_	_	VBN	_	_	_	_	_
38	invasively	_	_	RB	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	current	_	_	JJ	_	_	_	_	_
3	control	_	_	NN	_	_	_	_	_
4	approach	_	_	NN	_	_	_	_	_
5	uses	_	_	VBZ	_	_	_	_	_
6	flow	_	_	NN	_	_	_	_	_
7	pulsatility	_	_	NN	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	parameter	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	determine	_	_	VB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	required	_	_	VBN	_	_	_	_	_
15	flow	_	_	NN	_	_	_	_	_
16	rate	_	_	NN	_	_	_	_	_
17	compared	_	_	VBN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	continuous	_	_	JJ	_	_	_	_	_
21	pulsatility	_	_	NN	_	_	_	_	_
22	index	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	PI	_	_	NN	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	control	_	_	NN	_	_	_	_	_
27	strategy	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	which	_	_	WDT	_	_	_	_	_
30	regulates	_	_	VBZ	_	_	_	_	_
31	PI	_	_	NNP	_	_	_	_	_
32	directly	_	_	RB	_	_	_	_	_
33	at	_	_	IN	_	_	_	_	_
34	a	_	_	DT	_	_	_	_	_
35	specific	_	_	JJ	_	_	_	_	_
36	stage	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	allows	_	_	VBZ	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	left	_	_	JJ	_	_	_	_	_
5	ventricle	_	_	NN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	automatically	_	_	RB	_	_	_	_	_
8	adjust	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	RV	_	_	NN	_	_	_	_	_
11	output	_	_	NN	_	_	_	_	_
12	(	_	_	-LRB-	_	_	_	_	_
13	represented	_	_	VBN	_	_	_	_	_
14	by	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	increased	_	_	VBN	_	_	_	_	_
17	or	_	_	CC	_	_	_	_	_
18	decreased	_	_	VBN	_	_	_	_	_
19	pump	_	_	NN	_	_	_	_	_
20	pulsatility	_	_	NN	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	thereby	_	_	RB	_	_	_	_	_
24	decreasing	_	_	VBG	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	danger	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	suction	_	_	NN	_	_	_	_	_
29	or	_	_	CC	_	_	_	_	_
30	an	_	_	DT	_	_	_	_	_
31	inefficient	_	_	JJ	_	_	_	_	_
32	pumping	_	_	NN	_	_	_	_	_
33	aid	_	_	NN	_	_	_	_	_
34	connected	_	_	VBN	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	improperly	_	_	RB	_	_	_	_	_
37	defined	_	_	VBN	_	_	_	_	_
38	PI	_	_	NN	_	_	_	_	_
39	target	_	_	NN	_	_	_	_	_
40	values	_	_	NNS	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	optimal	_	_	JJ	_	_	_	_	_
3	target	_	_	NN	_	_	_	_	_
4	PI	_	_	NN	_	_	_	_	_
5	value	_	_	NN	_	_	_	_	_
6	depends	_	_	VBZ	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	heart	_	_	NN	_	_	_	_	_
9	contractility	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	preload	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	afterload	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	methodology	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	work	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	proposed	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	evaluate	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	merits	_	_	NNS	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	full-state	_	_	JJ	_	_	_	_	_
15	feedback	_	_	NN	_	_	_	_	_
16	control	_	_	NN	_	_	_	_	_
17	method	_	_	NN	_	_	_	_	_
18	involving	_	_	VBG	_	_	_	_	_
19	sensorless	_	_	JJ	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	non-invasive	_	_	JJ	_	_	_	_	_
22	approaches	_	_	NNS	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	a	_	_	DT	_	_	_	_	_
25	range	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	identical	_	_	JJ	_	_	_	_	_
28	simulation	_	_	NN	_	_	_	_	_
29	scenarios	_	_	NNS	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	method	_	_	NN	_	_	_	_	_
6	show	_	_	VBP	_	_	_	_	_
7	that	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	controller	_	_	NN	_	_	_	_	_
10	has	_	_	VBZ	_	_	_	_	_
11	advantages	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	regulating	_	_	VBG	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	reference	_	_	NN	_	_	_	_	_
16	signal	_	_	NN	_	_	_	_	_
17	generated	_	_	VBN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	safe	_	_	JJ	_	_	_	_	_
21	mode	_	_	NN	_	_	_	_	_
22	at	_	_	IN	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	variable	_	_	JJ	_	_	_	_	_
25	speed	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	as	_	_	IN	_	_	_	_	_
28	illustrated	_	_	VBN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	Figure	_	_	NN	_	_	_	_	_
31	4	_	_	CD	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	Figure	_	_	NN	_	_	_	_	_
34	5	_	_	CD	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	Figure	_	_	NN	_	_	_	_	_
37	6	_	_	CD	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	Figure	_	_	NN	_	_	_	_	_
40	7	_	_	CD	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	Figure	_	_	NN	_	_	_	_	_
43	8	_	_	CD	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	Figure	_	_	NN	_	_	_	_	_
46	9	_	_	CD	_	_	_	_	_
47	,	_	_	,	_	_	_	_	_
48	Figure	_	_	NN	_	_	_	_	_
49	10	_	_	CD	_	_	_	_	_
50	and	_	_	CC	_	_	_	_	_
51	Figure	_	_	NN	_	_	_	_	_
52	11	_	_	CD	_	_	_	_	_
53	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	software	_	_	NN	_	_	_	_	_
3	simulation	_	_	NN	_	_	_	_	_
4	model	_	_	NN	_	_	_	_	_
5	currently	_	_	RB	_	_	_	_	_
6	simulates	_	_	VBZ	_	_	_	_	_
7	rest	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	exercise	_	_	NN	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	changes	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	HR	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	cardiac	_	_	JJ	_	_	_	_	_
16	contractility	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	systemic	_	_	JJ	_	_	_	_	_
20	vascular	_	_	JJ	_	_	_	_	_
21	resistance	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Clinically	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	observed	_	_	VBN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	large	_	_	JJ	_	_	_	_	_
8	changes	_	_	NNS	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	pump	_	_	NN	_	_	_	_	_
11	pulsatility	_	_	NN	_	_	_	_	_
12	during	_	_	IN	_	_	_	_	_
13	postural	_	_	JJ	_	_	_	_	_
14	changes	_	_	NNS	_	_	_	_	_
15	cause	_	_	VBP	_	_	_	_	_
16	patients	_	_	NNS	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	sometimes	_	_	RB	_	_	_	_	_
19	feel	_	_	VB	_	_	_	_	_
20	weak	_	_	JJ	_	_	_	_	_
21	during	_	_	IN	_	_	_	_	_
22	Valsalva	_	_	NNP	_	_	_	_	_
23	maneuvers	_	_	NNS	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	e.	_	_	FW	_	_	_	_	_
26	g.	_	_	FW	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	when	_	_	WRB	_	_	_	_	_
29	coughing	_	_	VBG	_	_	_	_	_
30	or	_	_	CC	_	_	_	_	_
31	straining	_	_	VBG	_	_	_	_	_
32	)	_	_	-RRB-	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	believe	_	_	VBP	_	_	_	_	_
5	it	_	_	PRP	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	important	_	_	JJ	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	improve	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	software	_	_	NN	_	_	_	_	_
12	model	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	represent	_	_	VB	_	_	_	_	_
15	these	_	_	DT	_	_	_	_	_
16	events	_	_	NNS	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	aortic	_	_	JJ	_	_	_	_	_
6	valve	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	observed	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	be	_	_	VB	_	_	_	_	_
11	closed	_	_	VBN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	most	_	_	JJS	_	_	_	_	_
14	LVAD	_	_	NN	_	_	_	_	_
15	patients	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	change	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	posture	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	cardiac	_	_	JJ	_	_	_	_	_
10	recovery	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	during	_	_	IN	_	_	_	_	_
14	exercise	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	it	_	_	PRP	_	_	_	_	_
17	may	_	_	MD	_	_	_	_	_
18	open	_	_	VB	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	have	_	_	VBP	_	_	_	_	_
3	found	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	aortic	_	_	JJ	_	_	_	_	_
7	valve	_	_	NN	_	_	_	_	_
8	offers	_	_	VBZ	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	lower	_	_	JJR	_	_	_	_	_
11	resistance	_	_	NN	_	_	_	_	_
12	pathway	_	_	NN	_	_	_	_	_
13	than	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	LVAD	_	_	NNP	_	_	_	_	_
16	bypass	_	_	NN	_	_	_	_	_
17	route	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	as	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	native	_	_	JJ	_	_	_	_	_
22	heart	_	_	NN	_	_	_	_	_
23	sometimes	_	_	RB	_	_	_	_	_
24	pumps	_	_	VBZ	_	_	_	_	_
25	a	_	_	DT	_	_	_	_	_
26	significant	_	_	JJ	_	_	_	_	_
27	flow	_	_	NN	_	_	_	_	_
28	relative	_	_	JJ	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	that	_	_	DT	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	LVAD	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	believe	_	_	VBP	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	this	_	_	DT	_	_	_	_	_
7	different	_	_	JJ	_	_	_	_	_
8	pumping	_	_	NN	_	_	_	_	_
9	state	_	_	NN	_	_	_	_	_
10	could	_	_	MD	_	_	_	_	_
11	greatly	_	_	RB	_	_	_	_	_
12	impact	_	_	VB	_	_	_	_	_
13	our	_	_	PRP$	_	_	_	_	_
14	overall	_	_	JJ	_	_	_	_	_
15	control	_	_	NN	_	_	_	_	_
16	strategy	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	therefore	_	_	RB	_	_	_	_	_
20	requires	_	_	VBZ	_	_	_	_	_
21	online	_	_	JJ	_	_	_	_	_
22	detection	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	during	_	_	IN	_	_	_	_	_
5	use	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	clinical	_	_	JJ	_	_	_	_	_
9	setting	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	it	_	_	PRP	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	found	_	_	VBN	_	_	_	_	_
14	that	_	_	IN	_	_	_	_	_
15	controlling	_	_	VBG	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	pulsatility	_	_	NN	_	_	_	_	_
18	index	_	_	NN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	pre-set	_	_	JJ	_	_	_	_	_
22	point	_	_	NN	_	_	_	_	_
23	did	_	_	VBD	_	_	_	_	_
24	not	_	_	RB	_	_	_	_	_
25	prevent	_	_	VB	_	_	_	_	_
26	antagonistic	_	_	JJ	_	_	_	_	_
27	pumping	_	_	VBG	_	_	_	_	_
28	states	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	On	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	contrary	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	occasional	_	_	JJ	_	_	_	_	_
6	suction	_	_	NN	_	_	_	_	_
7	occurred	_	_	VBD	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	which	_	_	WDT	_	_	_	_	_
10	led	_	_	VBD	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	development	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	algorithms	_	_	NNS	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	anti-suction	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Another	_	_	DT	_	_	_	_	_
2	drawback	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	pulsatility	_	_	NN	_	_	_	_	_
7	index	_	_	NN	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	PI	_	_	NN	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	increasingly	_	_	RB	_	_	_	_	_
13	dependent	_	_	JJ	_	_	_	_	_
14	on	_	_	IN	_	_	_	_	_
15	heart	_	_	NN	_	_	_	_	_
16	rate	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	real-time	_	_	JJ	_	_	_	_	_
3	clinical	_	_	JJ	_	_	_	_	_
4	studies	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	we	_	_	PRP	_	_	_	_	_
7	plan	_	_	VBP	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	validate	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	controller	_	_	NN	_	_	_	_	_
12	built	_	_	VBN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	above-mentioned	_	_	JJ	_	_	_	_	_
16	computer	_	_	NN	_	_	_	_	_
17	simulation	_	_	NN	_	_	_	_	_
18	studies	_	_	NNS	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	pulsatile	_	_	JJ	_	_	_	_	_
22	mock	_	_	JJ	_	_	_	_	_
23	circulation	_	_	NN	_	_	_	_	_
24	loop	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	will	_	_	MD	_	_	_	_	_
3	include	_	_	VB	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	design	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	LabView/MATLAB	_	_	NNP	_	_	_	_	_
9	system	_	_	NN	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	implementation	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	control	_	_	NN	_	_	_	_	_
15	strategies	_	_	NNS	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	LVAD	_	_	NNP	_	_	_	_	_
19	physical	_	_	JJ	_	_	_	_	_
20	controller	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	computer	_	_	NN	_	_	_	_	_
3	system	_	_	NN	_	_	_	_	_
4	will	_	_	MD	_	_	_	_	_
5	then	_	_	RB	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	used	_	_	VBN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	acute	_	_	JJ	_	_	_	_	_
10	animal	_	_	NN	_	_	_	_	_
11	studies	_	_	NNS	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_

